4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0000919574-22-002418
Director bought 930,106 shares at an average $1.42 ($1,317,667)
From the SEC's structured data for this filing
Trades in this filing
BROADWOOD PARTNERS, L.P. · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-23 | Purchase : show line 1 in the form | +260,106 | $1.37 | $355,305 | 34,265,485 | D |
| 2022-03-23 | Purchase : show line 2 in the form | +0 | 34,265,485 | I | ||
| 2022-03-24 | Purchase : show line 3 in the form | +200,000 | $1.42 | $284,340 | 34,465,485 | D |
| 2022-03-24 | Purchase : show line 4 in the form | +0 | 34,465,485 | I | ||
| 2022-03-25 | Purchase : show line 5 in the form | +470,000 | $1.44 | $678,022 | 34,935,485 | D |
| 2022-03-25 | Purchase : show line 6 in the form | +0 | 34,935,485 | I | ||
| Open-market purchases · 930,106 sh · avg $1.42 · $1,317,667 | ||||||
Loading xslF345X03/ownership.xml…